The DOI matches its Crossref record; 91 of the 91 references it cites were found in a registry or an index.
Leucine-Rich Repeat Kinase 2 Mutations and Parkinson's Disease: Three Questions
Open accessAbstract
Mutations in the gene encoding LRRK2 (leucine-rich repeat kinase 2) were first identified in 2004 and have since been shown to be the single most common cause of inherited Parkinson's disease. The protein is a large GTP-regulated serine/threonine kinase that additionally contains several protein-protein interaction domains. In the present review, we discuss three important, but unresolved, questions concerning LRRK2. We first ask: what is the normal function of LRRK2? Related to this, we discuss the evidence of LRRK2 activity as a GTPase and as a kinase and the available data on protein-protein interactions. Next we raise the question of how mutations affect LRRK2 function, focusing on some slightly controversial results related to the kinase activity of the protein in a variety of in vitro systems. Finally, we discuss what the possible mechanisms are for LRRK2-mediated neurotoxicity, in the context of known activities of the protein.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Mutation in the α-Synuclein Gene Identified in Families with Parkinson's Disease
Polymeropoulos, M. H., Lavedan, C., Leroy, E., Ide, S. E., Dehejia, A., Dutra, A., Pike, B., Root, H., Rubenstein, J., Boyer, R., et al. (1997) · Science · doi:10.1126/science.276.5321.2045 · Cited by 8,240 · cited 1×
“Because we know that one of the major proteins found in Lewy bodies, a-synuclein, is also a gene for PD when mutated (Polymeropoulos et al., 1997; Kruger et al., 1998; Zarranz et al., 2004) or if expression is increased without any sequence variants (Singleton et al., 2003; Chartier-Harlin et al.,…”
BackgroundThe protein kinase complement of the human genome
Manning, G., Whyte, D. B., Martinez, R., Hunter, T., & Sudarsanam, S. (2002) · Science · doi:10.1126/science.1075762 · Cited by 8,145
α-Synuclein Locus Triplication Causes Parkinson's Disease
Singleton, A. B., Farrer, M., Johnson, J., Singleton, A., Hague, S., Kachergus, J., Hulihan, M., Peuralinna, T., Dutra, A., Nussbaum, R., et al. (2003) · Science · doi:10.1126/science.1090278 · Cited by 4,383
Self-citationAlaSOPro mutation in the gene encoding α-synuclein in Parkinson's disease
Krüger, R., Kuhn, W., Müller, T., Woitalla, D., Graeber, M., Kösel, S., Przuntek, H., Epplen, J. T., Schols, L., & Riess, O. (1998) · Nature Genetics · doi:10.1038/ng0298-106 · Cited by 3,836
Patterns of somatic mutation in human cancer genomes
Greenman, C., Stephens, P., Smith, R., Dalgliesh, G. L., Hunter, C., Bignell, G., Davies, H., Teague, J., Butler, A., Stevens, C., et al. (2007) · Nature · doi:10.1038/nature05610 · Cited by 3,080
Mutations in LRRK2 Cause Autosomal-Dominant Parkinsonism with Pleomorphic Pathology
Zimprich, A., Biskup, S., Leitner, P., Lichtner, P., Farrer, M., Lincoln, S., Kachergus, J., Hulihan, M., Uitti, R. J., Calne, D. B., et al. (2004) · Neuron · doi:10.1016/j.neuron.2004.11.005 · Cited by 3,005
The new mutation, E46K, of α‐synuclein causes parkinson and Lewy body dementia
Zarranz, J. J., Alegre, J., Gómez‐Esteban, J. C., Lezcano, E., Ros, R., Ampuero, I., Vidal, L., Hoenicka, J., Rodriguez, O., Atarés, B., et al. (2004) · Annals of Neurology · doi:10.1002/ana.10795 · Cited by 2,737
Cloning of the Gene Containing Mutations that Cause PARK8-Linked Parkinson's Disease
Paisán-Ruı́z, C., Jain, S., Evans, E. W., Gilks, W. P., Simón, J., van der Brug, M., de Munain, A. L., Aparicio, S., Gil, A. M., Khan, N., et al. (2004) · Neuron · doi:10.1016/j.neuron.2004.10.023 · Cited by 2,405
α-synuclein locus duplication as a cause of familial Parkinson's disease
Chartier-Harlin, M.-C., Kachergus, J., Roumier, C., Mouroux, V., Douay, X., Lincoln, S., Levecque, C., Larvor, L., Andrieux, J., Hulihan, M., et al. (2004) · The Lancet · doi:10.1016/s0140-6736(04)17103-1 · Cited by 2,029
Healy, D. G., Falchi, M., O'Sullivan, S. S., Bonifati, V., Durr, A., Bressman, S., Brice, A., Aasly, J., Zabetian, C. P., Goldwurm, S., et al. (2008) · The Lancet Neurology · doi:10.1016/s1474-4422(08)70117-0 · Cited by 1,425
Parkinson's disease-associated mutations in leucine-rich repeat kinase 2 augment kinase activity
West, A. B., Moore, D. J., Biskup, S., Bugayenko, A., Smith, W. W., Ross, C. A., Dawson, V. L., & Dawson, T. M. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0507360102 · Cited by 1,228 · cited 5×
“An alternative to autophosphoryla- tion as an assay for kinase activity is to use generic substrates such as MBP (myelin basic protein) (West et al., 2005; Iaccarino et al., 2007; Luzon-Toro et al., 2007).”
InfluentialA common LRRK2 mutation in idiopathic Parkinson's disease
Gilks, W. P., Abou-Sleiman, P. M., Gandhi, S., Jain, S., Singleton, A., Lees, A. J., Shaw, K., Bhatia, K. P., Bonifati, V., Quinn, N. P., et al. (2005) · The Lancet · doi:10.1016/s0140-6736(05)17830-1 · Cited by 774
Kinase activity is required for the toxic effects of mutant LRRK2/dardarin
Greggio, E., Jain, S., Kingsbury, A., Bandopadhyay, R., Lewis, P., Kaganovich, A., van der Brug, M. P., Beilina, A., Blackinton, J., Thomas, K. J., et al. (2006) · Neurobiology of Disease · doi:10.1016/j.nbd.2006.04.001 · Cited by 671
Self-citationA new locus for Parkinson's disease (PARK8) maps to chromosome 12p11.2–q13.1
Funayama, M., Hasegawa, K., Kowa, H., Saito, M., Tsuji, S., & Obata, F. (2002) · Annals of Neurology · doi:10.1002/ana.10113 · Cited by 667
THE BIOCHEMISTRY OF PARKINSON'S DISEASE
Cookson, M. R. (2005) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.74.082803.133400 · Cited by 664
Self-citationKinase activity of mutant LRRK2 mediates neuronal toxicity
Smith, W. W., Pei, Z., Jiang, H., Dawson, V. L., Dawson, T. M., & Ross, C. A. (2006) · Nature Neuroscience · doi:10.1038/nn1776 · Cited by 619
The Familial Parkinsonism Gene LRRK2 Regulates Neurite Process Morphology
MacLeod, D., Dowman, J., Hammond, R., Leete, T., Inoue, K., & Abeliovich, A. (2006) · Neuron · doi:10.1016/j.neuron.2006.10.008 · Cited by 564
West, A. B., Moore, D. J., Choi, C., Andrabi, S. A., Li, X., Dikeman, D., Biskup, S., Zhang, Z., Lim, K.-L., Dawson, V. L., et al. (2007) · Human Molecular Genetics · doi:10.1093/hmg/ddl471 · Cited by 533
Localization of LRRK2 to membranous and vesicular structures in mammalian brain
Biskup, S., Moore, D. J., Celsi, F., Higashi, S., West, A. B., Andrabi, S. A., Kurkinen, K., Yu, S., Savitt, J. M., Waldvogel, H. J., et al. (2006) · Annals of Neurology · doi:10.1002/ana.21019 · Cited by 511
Role of autophagy in G2019S‐LRRK2‐associated neurite shortening in differentiated SH‐SY5Y cells
Plowey, E. D., Cherra, S. J., Liu, Y., & Chu, C. T. (2008) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2008.05217.x · Cited by 493
The Parkinson disease causing LRRK2 mutation I2020T is associated with increased kinase activity
Gloeckner, C. J., Kinkl, N., Schumacher, A., Braun, R. J., O'Neill, E., Meitinger, T., Kolch, W., Prokisch, H., & Ueffing, M. (2006) · Human Molecular Genetics · doi:10.1093/hmg/ddi439 · Cited by 477
Jaleel, M., Nichols, R. J., Deak, M., Campbell, D. G., Gillardon, F., Knebel, A., & Alessi, D. R. (2007) · Biochemical Journal · doi:10.1042/bj20070209 · Cited by 472
Phosphorylation of 4E‐BP by LRRK2 affects the maintenance of dopaminergic neurons in Drosophila
Imai, Y., Gehrke, S., Wang, H., Takahashi, R., Hasegawa, K., Oota, E., & Lu, B. (2008) · The EMBO Journal · doi:10.1038/emboj.2008.163 · Cited by 430
Smith, W. W., Pei, Z., Jiang, H., Moore, D. J., Liang, Y., West, A. B., Dawson, V. L., Dawson, T. M., & Ross, C. A. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0508052102 · Cited by 424
LRRK2 regulates synaptic vesicle endocytosis
Shin, N., Jeong, H., Kwon, J., Heo, H. Y., Kwon, J. J., Yun, H. J., Kim, C.-H., Han, B. S., Tong, Y., Shen, J., et al. (2008) · Experimental Cell Research · doi:10.1016/j.yexcr.2008.02.015 · Cited by 329
Roc, a Ras/GTPase domain in complex proteins
Bosgraaf, L., & Van Haastert, P. J. M. (2003) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2003.08.008 · Cited by 320
Greggio, E., Zambrano, I., Kaganovich, A., Beilina, A., Taymans, J.-M., Daniëls, V., Lewis, P., Jain, S., Ding, J., Syed, A., et al. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m708718200 · Cited by 308
Self-citationGenetics of Parkinson's disease and parkinsonism
Hardy, J., Cai, H., Cookson, M. R., Gwinn‐Hardy, K., & Singleton, A. (2006) · Annals of Neurology · doi:10.1002/ana.21022 · Cited by 303
Self-citationA Drosophila model for LRRK2 -linked parkinsonism
Liu, Z., Wang, X., Yu, Y., Li, X., Wang, T., Jiang, H., Ren, Q., Jiao, Y., Sawa, A., Moran, T., et al. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0708452105 · Cited by 279
The R1441C mutation of LRRK2 disrupts GTP hydrolysis
Lewis, P. A., Greggio, E., Beilina, A., Jain, S., Baker, A., & Cookson, M. R. (2007) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2007.04.006 · Cited by 273
Self-citationRoss, O. A., Toft, M., Whittle, A. J., Johnson, J. L., Papapetropoulos, S., Mash, D. C., Litvan, I., Gordon, M. F., Wszolek, Z. K., Farrer, M. J., et al. (2006) · Annals of Neurology · doi:10.1002/ana.20731 · Cited by 268
An LRRK2 mutation as a cause for the parkinsonism in the original PARK8 family
Funayama, M., Hasegawa, K., Ohta, E., Kawashima, N., Komiyama, M., Kowa, H., Tsuji, S., & Obata, F. (2005) · Annals of Neurology · doi:10.1002/ana.20484 · Cited by 264
Ito, G., Okai, T., Fujino, G., Takeda, K., Ichijo, H., Katada, T., & Iwatsubo, T. (2007) · Biochemistry · doi:10.1021/bi061960m · Cited by 263
Deng, J., Lewis, P. A., Greggio, E., Sluch, E., Beilina, A., & Cookson, M. R. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0709098105 · Cited by 245
Self-citationLi, X., Tan, Y., Poulose, S., Olanow, C. W., Huang, X., & Yue, Z. (2007) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2007.04743.x · Cited by 230
Zimprich, A., Müller-Myhsok, B., Farrer, M., Leitner, P., Sharma, M., Hulihan, M., Lockhart, P., Strongosky, A., Kachergus, J., Calne, D. B., et al. (2004) · The American Journal of Human Genetics · doi:10.1086/380647 · Cited by 220
G2019S LRRK2 mutation in French and North African families with Parkinson's disease
Lesage, S., Ibanez, P., Lohmann, E., Pollak, P., Tison, F., Tazir, M., Leutenegger, A., Guimaraes, J., Bonnet, A., Agid, Y., et al. (2005) · Annals of Neurology · doi:10.1002/ana.20636 · Cited by 212
Guo, L., Gandhi, P. N., Wang, W., Petersen, R. B., Wilson-Delfosse, A. L., & Chen, S. G. (2007) · Experimental Cell Research · doi:10.1016/j.yexcr.2007.07.007 · Cited by 208
Lrrk2 G2385R is an ancestral risk factor for Parkinson's disease in Asia
Farrer, M. J., Stone, J. T., Lin, C.-H., Dächsel, J. C., Hulihan, M. M., Haugarvoll, K., Ross, O. A., & Wu, R.-M. (2007) · Parkinsonism & Related Disorders · doi:10.1016/j.parkreldis.2006.12.001 · Cited by 205
Goldwurm, S., Fonzo, A. D., Simons, E. J., Rohé, C. F., Zini, M., Canesi, M., Tesei, S., Zecchinelli, A., Antonini, A., Mariani, C., et al. (2005) · Journal of Medical Genetics · doi:10.1136/jmg.2005.035568 · Cited by 195
LRK-1, a C. elegans PARK8-Related Kinase, Regulates Axonal-Dendritic Polarity of SV Proteins
Sakaguchi-Nakashima, A., Meir, J. Y., Jin, Y., Matsumoto, K., & Hisamoto, N. (2007) · Current Biology · doi:10.1016/j.cub.2007.01.074 · Cited by 192
LRRK2 Gly2019Ser penetrance in Arab–Berber patients from Tunisia: a case-control genetic study
Hulihan, M. M., Ishihara-Paul, L., Kachergus, J., Warren, L., Amouri, R., Elango, R., Prinjha, R. K., Upmanyu, R., Kefi, M., Zouari, M., et al. (2008) · The Lancet Neurology · doi:10.1016/s1474-4422(08)70116-9 · Cited by 190
Apoptotic mechanisms in mutant LRRK2-mediated cell death
Iaccarino, C., Crosio, C., Vitale, C., Sanna, G., Carrì, M. T., & Barone, P. (2007) · Human Molecular Genetics · doi:10.1093/hmg/ddm080 · Cited by 190
Wang, L., Xie, C., Greggio, E., Parisiadou, L., Shim, H., Sun, L., Chandran, J., Lin, X., Lai, C., Yang, W.-J., et al. (2008) · The Journal of Neuroscience · doi:10.1523/jneurosci.0185-08.2008 · Cited by 188
Self-citationLRRK2 gene in Parkinson disease: Mutation analysis and case control association study
Paisán-Ruíz, C., Lang, A. E., Kawarai, T., Sato, C., Salehi-Rad, S., Fisman, G. K., Al-Khairallah, T., St George-Hyslop, P., Singleton, A., & Rogaeva, E. (2005) · Neurology · doi:10.1212/01.wnl.0000167552.79769.b3 · Cited by 178
Leucine-rich repeat kinase 2 associates with lipid rafts
Hatano, T., Kubo, S.-I., Imai, S., Maeda, M., Ishikawa, K., Mizuno, Y., & Hattori, N. (2007) · Human Molecular Genetics · doi:10.1093/hmg/ddm013 · Cited by 176
Ho, C. C., Rideout, H. J., Ribé, E. M., Troy, C. M., & Dauer, W. T. (2009) · Journal of Neuroscience · doi:10.1523/jneurosci.5175-08.2009 · Cited by 176
The Roc domain of leucine‐rich repeat kinase 2 is sufficient for interaction with microtubules
Gandhi, P. N., Wang, X., Zhu, X., Chen, S. G., & Wilson‐Delfosse, A. L. (2008) · Journal of Neuroscience Research · doi:10.1002/jnr.21622 · Cited by 168
The Parkinson Disease Gene LRRK2: Evolutionary and Structural Insights
Marín, I. (2006) · Molecular Biology and Evolution · doi:10.1093/molbev/msl114 · Cited by 165
Loss of LRRK2/PARK8 induces degeneration of dopaminergic neurons in Drosophila
Lee, S. B., Kim, W., Lee, S., & Chung, J. (2007) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2007.04.156 · Cited by 159
Gotthardt, K., Weyand, M., Kortholt, A., Van Haastert, P. J. M., & Wittinghofer, A. (2008) · The EMBO Journal · doi:10.1038/emboj.2008.150 · Cited by 159
Dynamic and redundant regulation of LRRK2 and LRRK1 expression
Biskup, S., Moore, D. J., Rea, A., Lorenz-Deperieux, B., Coombes, C. E., Dawson, V. L., Dawson, T. M., & West, A. B. (2007) · BMC Neuroscience · doi:10.1186/1471-2202-8-102 · Cited by 158
Paglini, M. G., Kunda, P. E., Quiroga, S., Kosik, K. S., & Cáceres, A. (1998) · The Journal of Cell Biology · doi:10.1083/jcb.143.2.443 · Cited by 157
The LRRK2 G2019S mutation in Ashkenazi Jews with Parkinson disease
Orr‐Urtreger, A., Shifrin, C., Rozovski, U., Rosner, S., Bercovich, D., Gurevich, T., Yagev-More, H., Bar‐Shira, A., & Giladi, N. (2007) · Neurology · doi:10.1212/01.wnl.0000277637.33328.d8 · Cited by 155
Lrrk2 R1441C parkinsonism is clinically similar to sporadic Parkinson disease
Haugarvoll, K., Rademakers, R., Kachergus, J. M., Nuytemans, K., Ross, O. A., Gibson, J. M., Tan, E., Gaig, C., TOLOSA, E. S., Goldwurm, S., et al. (2008) · Neurology · doi:10.1212/01.wnl.0000304044.22253.03 · Cited by 154
A clinic-based study of the LRRK2 gene in Parkinson disease yields new mutations
Zabetian, C. P., Samii, A., Mosley, A. D., Roberts, J. W., Leis, B. C., Yearout, D., Raskind, W. H., & Griffith, A. (2005) · Neurology · doi:10.1212/01.wnl.0000172630.22804.73 · Cited by 150
The Roco protein family: a functional perspective
Marín, I., van Egmond, W. N., & Haastert, P. J. M. V. (2008) · The FASEB Journal · doi:10.1096/fj.08-111310 · Cited by 143
Zabetian, C. P., Hutter, C. M., Yearout, D., Lopez, A. N., Factor, S. A., Griffith, A., Leis, B. C., Bird, T. D., Nutt, J. G., Higgins, D. S., et al. (2006) · The American Journal of Human Genetics · doi:10.1086/508025 · Cited by 131
Dispensable role of Drosophila ortholog of LRRK2 kinase activity in survival of dopaminergic neurons
Wang, D., Tang, B., Zhao, G., Pan, Q., Xia, K., Bodmer, R., & Zhang, Z. (2008) · Molecular Neurodegeneration · doi:10.1186/1750-1326-3-3 · Cited by 128
Investigation of leucine‐rich repeat kinase 2: Enzymological properties and novel assays
Anand, V. S., Reichling, L. J., Lipinski, K., Stochaj, W. R., Duan, W., Kelleher, K. S., Pungaliya, P., Brown, E. L., Reinhart, P. H., Somberg, R. L., et al. (2008) · FEBS Journal · doi:10.1111/j.1742-4658.2008.06789.x · Cited by 127
Luzon-Toro, B., de la Torre, E. R., Delgado, A., Perez-Tur, J., & Hilfiker, S. (2007) · Human Molecular Genetics · doi:10.1093/hmg/ddm151 · Cited by 122
Hasegawa, K., Stoessl, A. J., Yokoyama, T., Kowa, H., Wszołek, Z. K., & Yagishita, S. (2008) · Parkinsonism & Related Disorders · doi:10.1016/j.parkreldis.2008.07.010 · Cited by 118
LRRK1 protein kinase activity is stimulated upon binding of GTP to its Roc domain
Korr, D., Toschi, L., Donner, P., Pohlenz, H., Kreft, B., & Weiss, B. (2005) · Cellular Signalling · doi:10.1016/j.cellsig.2005.08.015 · Cited by 115
G2019S LRRK2 mutation causing Parkinson's disease without Lewy bodies
Gaig, C., Martı́, M. J., Ezquerra, M., Rey, M. J., Cardozo, A., & TOLOSA, E. S. (2007) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp.2006.107904 · Cited by 112
Melrose, H. L., Kent, C., Taylor, J. P., Dächsel, J. C., Hinkle, K. M., Lincoln, S. J., Mok, S. S., Culvenor, J. G., Masters, C. L., Tyndall, G., et al. (2007) · Neuroscience · doi:10.1016/j.neuroscience.2007.05.027 · Cited by 109
Genetic neuropathology of Parkinson's disease.
Cookson, M., Hardy, J., & Lewis, P. A. (2008) · PubMed Central · Cited by 108
Self-citationPaisán‐Ruiz, C., Nath, P., Washecka, N., Gibbs, J. R., & Singleton, A. (2008) · Human Mutation · doi:10.1002/humu.20668 · Cited by 108
Direct binding of α‐actinin enhances TRPP3 channel activity
Li, Q., Dai, X., Shen, P. Y., Wu, Y., Long, W., Chen, C. X., Hussain, Z., Wang, S., & Chen, X. (2007) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2007.04940.x · Cited by 105
Latourelle, J. C., Sun, M., Lew, M., Suchowersky, O., Klein, C., Golbe, L. I., Mark, M. H., Growdon, J. H., Wooten, G. F., Watts, R. L., et al. (2008) · BMC Medicine · doi:10.1186/1741-7015-6-32 · Cited by 105
Wild-type LRRK2 but not its mutant attenuates stress-induced cell death via ERK pathway
Liou, A. K. F., Leak, R. K., Li, L., & Zigmond, M. J. (2008) · Neurobiology of Disease · doi:10.1016/j.nbd.2008.06.016 · Cited by 104
Identification of compounds that inhibit the kinase activity of leucine-rich repeat kinase 2
Covy, J. P., & Giasson, B. I. (2008) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2008.11.048 · Cited by 101
LRRK2 R1441G in Spanish patients with Parkinson's disease
Mata, I. F., Taylor, J. P., Kachergus, J. M., Hulihan, M., Huerta, C., Lahoz, C., Estrada, M. B., Guisasola, L. M., Salvador, C., Ribacoba, R., et al. (2005) · Neuroscience Letters · doi:10.1016/j.neulet.2005.03.033 · Cited by 98
Ishihara, L., Gibson, R. A., Warren, L. L., Amouri, R., Lyons, K. E., Wielinski, C. L., Hunter, C., Swartz, J., Elango, R., Akkari, P. A., et al. (2006) · Movement Disorders · doi:10.1002/mds.21180 · Cited by 93
Greggio, E., Lewis, P. A., van der Brug, M. P., Ahmad, R., Kaganovich, A., Ding, J., Beilina, A. G., Baker, A. K., & Cookson, M. (2007) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2007.04523.x · Cited by 90
Self-citationIdentification of potential protein interactors of Lrrk2
Dächsel, J. C., Taylor, J. P., Mok, S. S., Ross, O. A., Hinkle, K. M., Bailey, R. M., Hines, J. H., Szutu, J., Madden, B. J., Petrucelli, L., et al. (2007) · Parkinsonism & Related Disorders · doi:10.1016/j.parkreldis.2007.01.008 · Cited by 84
Cookson, M., Xiromerisiou, G., & Singleton, A. (2005) · Current Opinion in Neurology · doi:10.1097/01.wco.0000186841.43505.e6 · Cited by 81
Self-citationAncient Origin of the Parkinson Disease Gene LRRK2
Marín, I. (2008) · Journal of Molecular Evolution · doi:10.1007/s00239-008-9122-4 · Cited by 81
Gorostidi, A., Ruiz‐Martínez, J., de Munaín, A. L., Alzualde, A., & Martí-Massó, J. F. (2008) · Neurogenetics · doi:10.1007/s10048-008-0162-0 · Cited by 81
High prevalence of LRRK2 mutations in familial and sporadic Parkinson's disease in Portugal
Ferreira, J. J., Guedes, L. C., Rosa, M. M., Coelho, M. M., van Doeselaar, M., Schweiger, D., Fonzo, A. D., Oostra, B. A., Sampaio, C., & Bonifati, V. (2007) · Movement Disorders · doi:10.1002/mds.21525 · Cited by 79
Escaping Parkinson's disease: A neurologically healthy octogenarian with the LRRK2 G2019S mutation
Kay, D. M., Kramer, P., Higgins, D. S., Zabetian, C. P., & Payami, H. (2005) · Movement Disorders · doi:10.1002/mds.20618 · Cited by 76
Identification and haplotype analysis of LRRK2 G2019S in Japanese patients with Parkinson disease
Zabetian, C. P., Morino, H., Ujike, H., Yamamoto, M., Oda, M., Maruyama, H., Izumi, Y., Kaji, R., Griffith, A., Leis, B. C., et al. (2006) · Neurology · doi:10.1212/01.wnl.0000227732.37801.d4 · Cited by 60
Lin, C., Tzen, K., Yu, C.-Y., Tai, C., Farrer, M. J., & Wu, R. (2008) · Journal of Biomedical Science · doi:10.1007/s11373-008-9260-0 · Cited by 58
Analysis of Parkinson disease patients from Portugal for mutations in SNCA, PRKN, PINK1 and LRRK2
Brás, J., Guerreiro, R. J., Ribeiro, M., Morgadinho, A., Januário, C., Dias, M. S., Calado, A. C. D. L., Semedo, C., Oliveira, C. R., Hardy, J., et al. (2008) · BMC Neurology · doi:10.1186/1471-2377-8-1 · Cited by 55
The function of ROCO proteins in health and disease
Lewis, P. A. (2009) · Biology of the Cell · doi:10.1042/bc20080053 · Cited by 53
Identification of a Common Genetic Risk Variant (LRRK2 Gly2385Arg) in Parkinson’s Disease
Tan, E. (2006) · Annals of the Academy of Medicine Singapore · doi:10.47102/annals-acadmedsg.v35n11p840 · Cited by 39
Haplotype analysis of Lrrk2 R1441H carriers with parkinsonism
Ross, O. A., Spanaki, C., Griffith, A., Lin, C., Kachergus, J. M., Haugarvoll, K., Latsoudis, H., Plaitakis, A., Ferreira, J. J., Sampaio, C., et al. (2008) · Parkinsonism & Related Disorders · doi:10.1016/j.parkreldis.2008.09.001 · Cited by 35
Saunders-Pullman, R. J., Lipton, R. B., Senthil, G., Katz, M. J., Costan-Toth, C., Derby, C. A., Bressman, S., Verghese, J., & Ozelius, L. J. (2006) · Neuroscience Letters · doi:10.1016/j.neulet.2006.03.044 · Cited by 35
LRRK2 G2385R modulates age at onset in Parkinson's disease: A multi‐center pooled analysis
Tan, E., Peng, R., Wu, Y., Wu, R., Chou, Y. W., Tan, L. C. S., An, X., Chen, C. M., Fook-Chong, S. M. C., & Lu, C.-S. (2009) · American Journal of Medical Genetics Part B Neuropsychiatric Genetics · doi:10.1002/ajmg.b.30923 · Cited by 34
Pankratz, N., Pauciulo, M. W., Elsaesser, V. E., Marek, D. K., Halter, C. A., Rudolph, A., Shults, C. W., Foroud, T., & Nichols, W. C. (2006) · Movement Disorders · doi:10.1002/mds.21162 · Cited by 33
Chan, D. K. Y., Ng, P. W., Mok, V., Yeung, J. H. M., Fang, Z. M., Clarke, R. A., Leung, E. M.-F., & Wong, K. S. (2008) · Journal of Neural Transmission · doi:10.1007/s00702-008-0065-0 · Cited by 22
Coronin Structure and Implications
McArdle, B. M., & Hofmann, A. (2008) · Sub-cellular biochemistry/Subcellular biochemistry · doi:10.1007/978-0-387-09595-0_6 · Cited by 20
Cited by
Clinical progression in Parkinson disease and the neurobiology of axons
Cheng, H., Ulane, C. M., & Burke, R. E. (2010) · Annals of Neurology · doi:10.1002/ana.21995 · Cited by 1,012
“netic cause of typical PD is mutations in the gene for leucine rich repeat kinase 2 (LRRK2).(42) The recent de-”
BackgroundKinase inhibitors: the road ahead
Ferguson, F. M., & Gray, N. S. (2018) · Nature Reviews Drug Discovery · doi:10.1038/nrd.2018.21 · Cited by 1,009
What Genetics Tells us About the Causes and Mechanisms of Parkinson's Disease
Corti, O., Lesage, S., & Brice, A. (2011) · Physiological Reviews · doi:10.1152/physrev.00022.2010 · Cited by 611
The role of leucine-rich repeat kinase 2 (LRRK2) in Parkinson's disease
Cookson, M. R. (2010) · Nature Reviews Neuroscience · doi:10.1038/nrn2935 · Cited by 539
Self-citationAxon degeneration in Parkinson's disease
Burke, R. E., & O'Malley, K. (2013) · Experimental Neurology · doi:10.1016/j.expneurol.2012.01.011 · Cited by 493
Metadata
- Authors
- Greggio, E., & Cookson, M. R.
- Venue
- ASN Neuro
- Publisher
- Informa UK Limited
- Published
- 2009-01
- Volume
- 1
- Issue
- 1
- ISSN
- 1759-0914 (ISSN-L)
- OpenAlex
- W2072216745
- Cited by
- 272
- References
- 91
- FWCI
- 18.38
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.